Candidates must normally possess: at least a second class honours degree in Life Science or Pharmacy/Pharmacology from a university in the United Kingdom; or a qualification deemed by the Joint Management Committee to be equivalent to the above; and/or professional or industrial experience deemed appropriate by the Joint Management Further information regarding academic entry requirements: firstname.lastname@example.org English language requirements For applicants whose first language is not English, the University sets a minimum English Language proficiency level. International English Language Testing System (IELTS) Academic module (not General Training): overall score 6.5 no sub-test less than 6.0 or equivalent scores in another recognised qualification (see below) Common equivalent English language qualifications: ibTOEFL: 92; no sub-test less than 20 CAE (Cambridge Certificate of Advanced English): B minimum CPE (Cambridge Certificate of Proficiency in English): C minimum PTE Academic (Person Test of English, Academic test): 60; no sub-test less than 59 Pre-sessional courses The University of Glasgow accepts evidence of the required language level from the Language Centre Pre-sessional courses. We also consider other BALEAP accredited pre-sessional courses: Language Centre, University of Glasgow BALEAP guide to accredited courses Visa requirements and proof of English language level It is a visa requirement to provide information on your level of English based on an internationally recognised and secure English language test. All test reports must be no more than 2 years old. A list of these can be found on the UK Border Agency website. If you have never taken one of these tests before, you can get an initial idea of your level by using the Common European Framework self-assessment grid which gives you a level for each skill (e.g. listening B1/writing B2 etc.) However, please note that this is not a secure English language test and it is not sufficient evidence of your level of English for visa requirements. If you require a Tier 4 student visa, your qualification must be one of the secure English language tests accepted by UK Border Agency.
Months of entry
Stratified Medicine holds huge potential in the timely development of new treatments for human disease. It is among the most important concepts to emerge in 21st century clinical science and will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new treatments. This new taught postgraduate Masters programme draws on the current and future needs of the Life Sciences sector, to create a highly skilled workforce and is being developed in conjunction with the industrial partners of the Stratified Medicine Scotland Innovation Centre (SMS-IC). It harnesses Scotland’s strengths in Stratified Medicine, Clinical Trials, Bioinformatics and Pharmacogenomics to provide focused training which integrates basic and clinical sciences, and equips students with grounding in the essential skills required to design, execute and evaluate modern clinical interventions.
- Students will be given the unique opportunity to undertake an industry placement as their main project. This fantastic opportunity will be offered by partner commercial organisations/companies and universities.
- The programme will cover aspects of commercial innovation and entrepreneurial skills, together with the principles which underpin the emerging science at the interface between genetics and pharmacology.
- Students on the programme will undergo theoretical and practical training in state-of-the-art research processes, enabling an appreciation of how to applynovel stratified approaches, together with clinical pharmacological, regulatory and ethical principles to the optimisation of future clinical research and therapeutic practice.
- Students will also gain an understanding of statistical methods used to evaluate the efficacy and cost-effectiveness of new treatments, and direct experience of how all of these techniques are applied by academic and industrial researchers in the development of new medicines.
- Following successful completion of the programme a joint master’s degree will be awarded.
- The five stakeholder universities, Glasgow, Aberdeen, Strathclyde, Dundee and Edinburgh are internationally recognised as leaders in biomedical research, hosting highly collaborative and productive groups with the requisite expertise in pharmacology, clinical trial methodology, pharmacogenomics, and life sciences. This vibrant environment, coupled with Scotland’s tradition of excellence in clinical research and significant recent investment in the new science of Stratified Medicine make it the ideal place to acquire the transferrable skills required for a successful and fulfilling career in 21st century biomedicine.
Students will be offered a choice of base institution, either Glasgow or Aberdeen. In addition both groups of students will participate in modules/courses provided by the Universities of Dundee and Strathclyde. Tuition will comprise (a) core modules/courses (60 credits) and a series of optional modules/courses (60 credits) which enable participating students to personalise their degree better to align it with their future career aspirations. Students will also be offered a choice of project, which will afford them the opportunity to gain employability skills and to apply their new knowledge in a commercial or academic context. Further flexibility will be provided through a choice of host institution for some modules, and distance learning options for others.
- Scientific basis of stratified medicine
- Commercialisation of Science
- Application of research and evaluation technologies
- Pharmaceutical Medicine
- Drug disposition
- Interdisciplinary Integrative Skills
- Advanced Bio-business
- New Venture Creation
- Applied Health Economics
- Clinical Trail Methodology
- Developing Research and Evaluation Skills
- Challenges of Drug Development
- Health Informatics
- Spatial Epidemiology
- Quantitative Research Methods
- Systemic Reviews
- Genome Enabled Medicine
- Pharmacokinetics and Toxicokinetics
- Biologic Drug Discovery
- Laboratory techniques: Core practical skills
Project and Assessment
- The project will account for the remaining 60 credits. All projects will either have an industrial placement or a project which addresses an industrial need. The programme will include an opportunity for all students to present the outcomes of their projects to an audience of other students, academics and industry representatives. Assessment will consist of submission of a Dissertation and a viva voce examination.
Information for international students
IELTS: overall score 6.5; no sub-test less than 6.0; ibTOEFL: 92; no sub-test less than 20. CAE: 176 overall; no sub-test less than 169 CPE: 176 overall; no sub-test less than 169. PTE Academic: 60; no sub-test less than 59
Fees and funding
Qualification and course duration
Course contact details
- Institute of Cardiovascular and Medical Sciences